Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
713 (USA) · Dr. Kowalski
consented 2013-05-27
AEs
4
Serious
0
Dropout signal
–
Adverse events
mild
assessed
Mild ABDOMINAL PAIN — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-30 (study day 4.0); relationship: POSSIBLE
moderate
assessed
Moderate ABDOMINAL PAIN — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-30 (study day 4.0); relationship: POSSIBLE
mild
assessed
Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-02 (study day 7.0); relationship: PROBABLE
mild
assessed
Mild DIZZINESS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-10-31 (study day 158.0); relationship: POSSIBLE
Data queries
No data queries.